Optimal Dose of Omeprazole After Endoscopic Treatment of Bleeding Peptic Ulcers
NCT00519519 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 126
Last updated 2017-02-10
Summary
Bleeding peptic ulcers are one of the major causes of morbidity and mortality for hospital emergency admissions.The initial treatment is endoscopic therapy followed by intravenous omeprazole. However the optimal dosage of omeprazole is not known. We conducted this study to find out the optimal dosage in such clinical scenario.
Conditions
- Bleeding Peptic Ulcers Disease
Interventions
- DRUG
-
Omeprazole
intravenous 80mg bolus followed by 8mg / hr for 3 days
Sponsors & Collaborators
-
Singapore General Hospital
lead OTHER
Principal Investigators
-
Weng Hoong Chan, MBBS, FRCS · Singapore General Hospital
-
Weng Hoong Chan, MBBS, FRCS · Department of Surgery, Singapore General Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-07-31
- Primary Completion
- 2007-10-31
- Completion
- 2007-11-30
Countries
- Singapore
Study Locations
More Related Trials
-
Efficacy of Vonoprazan Versus Intravenous Proton Pump Inhibitors for Prevention of Rebleeding in High Risk Peptic Ulcers Bleeding After Successful Endoscopic Hemostasis
NCT05005910 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Efficacy and Safety Study of Esomeprazole vs Omeprazole to Treat Acute Non-Variceal Upper Gastrointestinal Bleeding
NCT00402259 ·Status: COMPLETED ·Phase: PHASE3
-
Administration of High-Dose Intravenous Proton Pump Inhibitor for Upper Gastrointestinal Bleeding Prior to Endoscopy
NCT00164866 ·Status: COMPLETED ·Phase: PHASE4
-
Single Dose Omeprazole Versus High Dose in High-risk Critically Ill Patients.
NCT03388463 ·Status: COMPLETED ·Phase: NA
-
The Efficacy of Double Doses of Oral Esomeprazole in Preventing Rebleeding for Patients With Bleeding Peptic Ulcers
NCT01591083 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Intravenous Omeprazole to Ranitidine on Recurrent Bleeding After Endoscopic Treatment of Bleeding Ulcer
NCT00247130 ·Status: WITHDRAWN ·Phase: PHASE4
-
Efficacy of Low Dose of Proton Pump Inhibitor in Treatment Bleeding Ulcers
NCT03163680 ·Status: COMPLETED
-
IIaprazole for the Treatment and Prevention of Peptic Ulcer Bleeding in Chinese Patients
NCT03362268 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of 2 Different Doses of Pantoprazole on Gastric pH and Recurrent Bleeding in Patients Who Bled From Peptic Ulcers
NCT00279123 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Different Omeprazole Dosing on Gastric pH in Non-variceal Upper Gastrointestinal Bleeding
NCT03980496 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Low Against High Regimen of Proton Pump Inhibitors for Treatment of Acute Peptic Ulcer Bleeding
NCT02724150 ·Status: WITHDRAWN ·Phase: PHASE4
-
Ilaprazole for the Treatment and Prevention of Peptic Ulcer Bleeding in Chinese Patients
NCT03362281 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Oral Rabeprazole vs. iv Omeprazole in Mild to Moderate Nonvariceal Upper Gastrointestinal Bleeding
NCT00861640 ·Status: UNKNOWN ·Phase: PHASE4
-
A Double Blind Study Comparing Two Doses of IV Esomeprazole After Successful Endoscopic Therapy
NCT01275937 ·Status: UNKNOWN ·Phase: PHASE4
-
Study Evaluating Pantoprazole in Peptic Ulcer Hemorrhage
NCT00040495 ·Status: COMPLETED ·Phase: PHASE3
-
Comparing Two Doses of IV Esomeprazole After Successful Endoscopic Therapy
NCT04407832 ·Status: WITHDRAWN ·Phase: NA
-
Effect of High-dose Oral Rabeprazole on Recurrent Bleeding After the Endoscopic Treatment of Bleeding Peptic Ulcers
NCT00838682 ·Status: TERMINATED ·Phase: PHASE4
-
High Dose Esomeprazole Na for Prevention of Rebleeding After Successful Endoscopic Therapy of a Bleeding Peptic Ulcer
NCT01757275 ·Status: COMPLETED ·Phase: PHASE3
-
The Use of Oral Omeprazole and Intravenous Pantoprazole in Patients With Hypersecretion of Gastric Acid
NCT00001191 ·Status: COMPLETED ·Phase: PHASE2
-
Compare Efficacy of Gastric Acid Suppression by Oral and Intravenous Administration of Esomeprazole in Patients With Peptic Ulcer
NCT00471029 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy of Low Dose Intravenous Proton Pump Inhibitor for Peptic Ulcer Bleeding
NCT03814421 ·Status: UNKNOWN ·Phase: NA
-
Safety & Efficacy of Omeprazole Sodium Bicarbonate for the Prevention of Upper GI Bleeding in the Critically Ill
NCT00045799 ·Status: COMPLETED ·Phase: PHASE3
-
Influence of CYP2C19 Polymorphism on PK/PD of Omeprazole
NCT02299687 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Assess the Pharmacodynamics/Pharmacokinetics After Repeated Dosing of D961H 10 mg and Omeprazole 10 mg in Japanese Healthy Male Subjects
NCT01159145 ·Status: COMPLETED ·Phase: PHASE1
-
High Versus Standard Dose of Proton Pump Inhibitors (PPIs) in Peptic Ulcer Bleeding
NCT00374101 ·Status: COMPLETED ·Phase: PHASE3